TY - JOUR
T1 - Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury
AU - Figueroa, Johnny D.
AU - Cordero, Kathia
AU - Llán, Miguel S.
AU - De Leon, Marino
N1 - If the address matches an existing account you will receive an email with instructions to reset your password
PY - 2013/5/15
Y1 - 2013/5/15
N2 - Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) confer multiple health benefits and decrease the risk of neurological disorders. Studies are needed, however, to identify promising cellular targets and to assess their prophylactic value against neurodegeneration. The present study (1) examined the efficacy of a preventive diet enriched with ω-3 PUFAs to reduce dysfunction in a well-established spinal cord injury (SCI) animal model and (2) used a novel metabolomics data analysis to identify potential neurolipidomic targets. Rats were fed with either control chow or chow enriched with ω-3 PUFAs (750 mg/kg/day) for 8 weeks before being subjected to a sham or a contusion SCI operation. We report new evidence showing that rats subjected to SCI after being pre-treated with a diet enriched with ω-3 PUFAs exhibit significantly better functional outcomes. Pre-treated animals exhibited lower sensory deficits, autonomic bladder recovery, and early improvements in locomotion that persisted for at least 8 weeks after trauma. We found that SCI triggers a robust alteration in the cord PUFA neurolipidome, which was characterized by a marked docosahexaenoic acid (DHA) deficiency. This DHA deficiency was associated with dysfunction and corrected with the ω-3 PUFA-enriched diet. Multivariate data analyses revealed that the spinal cord of animals consuming the ω-3 PUFA-enriched diet had a fundamentally distinct neurolipidome, particularly increasing the levels of essential and long chain ω-3 fatty acids and lysolipids at the expense of ω-6 fatty acids and its metabolites. Altogether, dietary ω-3 PUFAs prophylaxis confers resiliency to SCI mediated, at least in part, by generating a neuroprotective and restorative neurolipidome. © Copyright 2013, Mary Ann Liebert, Inc. 2013.
AB - Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) confer multiple health benefits and decrease the risk of neurological disorders. Studies are needed, however, to identify promising cellular targets and to assess their prophylactic value against neurodegeneration. The present study (1) examined the efficacy of a preventive diet enriched with ω-3 PUFAs to reduce dysfunction in a well-established spinal cord injury (SCI) animal model and (2) used a novel metabolomics data analysis to identify potential neurolipidomic targets. Rats were fed with either control chow or chow enriched with ω-3 PUFAs (750 mg/kg/day) for 8 weeks before being subjected to a sham or a contusion SCI operation. We report new evidence showing that rats subjected to SCI after being pre-treated with a diet enriched with ω-3 PUFAs exhibit significantly better functional outcomes. Pre-treated animals exhibited lower sensory deficits, autonomic bladder recovery, and early improvements in locomotion that persisted for at least 8 weeks after trauma. We found that SCI triggers a robust alteration in the cord PUFA neurolipidome, which was characterized by a marked docosahexaenoic acid (DHA) deficiency. This DHA deficiency was associated with dysfunction and corrected with the ω-3 PUFA-enriched diet. Multivariate data analyses revealed that the spinal cord of animals consuming the ω-3 PUFA-enriched diet had a fundamentally distinct neurolipidome, particularly increasing the levels of essential and long chain ω-3 fatty acids and lysolipids at the expense of ω-6 fatty acids and its metabolites. Altogether, dietary ω-3 PUFAs prophylaxis confers resiliency to SCI mediated, at least in part, by generating a neuroprotective and restorative neurolipidome. © Copyright 2013, Mary Ann Liebert, Inc. 2013.
KW - DHA
KW - Functional recovery
KW - Lipidomics
KW - Prevention
KW - Spinal Cord Injuries/drug therapy
KW - Locomotion/drug effects
KW - Dietary Fats/administration & dosage
KW - Rats
KW - Rats, Sprague-Dawley
KW - Recovery of Function/drug effects
KW - Docosahexaenoic Acids/metabolism
KW - Animals
KW - Fatty Acids, Omega-3/administration & dosage
KW - Female
KW - Spinal Cord/drug effects
KW - Motor Skills/drug effects
UR - http://www.scopus.com/inward/record.url?scp=84878316964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878316964&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/12ef0aa9-8504-30b4-b651-5673d0e25487/
U2 - 10.1089/neu.2012.2718
DO - 10.1089/neu.2012.2718
M3 - Article
C2 - 23294084
SN - 0897-7151
VL - 30
SP - 853
EP - 868
JO - Journal of Neurotrauma
JF - Journal of Neurotrauma
IS - 10
ER -